Malignant syndrome in Parkinson's disease [2]

Parkinsonism and Related Disorders

Volumn 10, Issue 2, 2003, Pages 115-116

  Linazasoro, Gurutz ^a  

^a HOSPITAL QUIRÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENZODIAZEPINE; CARBIDOPA PLUS LEVODOPA; LISURIDE; SELEGILINE;

AGED; ANAMNESIS; BLOOD PRESSURE MONITORING; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; HEART RATE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; LOW DRUG DOSE; MALIGNANT SYNDROME; PARKINSON DISEASE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0345687946     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2003.09.001     Document Type: Letter

References (3)

1. Mizuno Y., Takubo H., Mizuta E., Kuno S. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Related Disord. 9:2003;S3-S9.
2. Obeso J.A., Linazasoro G., Gorospe A., et al. Complications associated with chronic levodopa therapy in Parkinson's disease. Olanow C.W., Obeso J.A. Beyond the decade of the brain. vol. 2:1997;11-36 Wells Medical Ltd, Kent.
3. Pfeiffer R.F., Sucha E.L. On-off-induced lethal hyperthermia. Mov Disord. 4:1989;338-341.